These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 28625716)

  • 101. The role of HIF in cobalt-induced ischemic tolerance.
    Jones SM; Novak AE; Elliott JP
    Neuroscience; 2013 Nov; 252():420-30. PubMed ID: 23916558
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Inhibition of a viral prolyl hydroxylase.
    Langley GW; Abboud MI; Lohans CT; Schofield CJ
    Bioorg Med Chem; 2019 Jun; 27(12):2405-2412. PubMed ID: 30737136
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease.
    Kaplan JM; Sharma N; Dikdan S
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29382128
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors.
    Deng G; Zhao B; Ma Y; Xu Q; Wang H; Yang L; Zhang Q; Guo TB; Zhang W; Jiao Y; Cai X; Zhang J; Liu H; Guan X; Lu H; Xiang J; Elliott JD; Lin X; Ren F
    Bioorg Med Chem; 2013 Nov; 21(21):6349-58. PubMed ID: 24055079
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features.
    An X; Xu G; Yang L; Wang Y; Li Y; McHepange UO; Shen G; Tu Y; Tao J
    J Dermatol; 2014 Jan; 41(1):76-83. PubMed ID: 24354513
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Neuronal prolyl-4-hydroxylase 2 deficiency improves cognitive abilities in a murine model of cerebral hypoperfusion.
    Gruneberg D; Montellano FA; Plaschke K; Li L; Marti HH; Kunze R
    Exp Neurol; 2016 Dec; 286():93-106. PubMed ID: 27720797
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Lactoferrin from bovine colostrum regulates prolyl hydroxylase 2 activity and prevents prion protein-mediated neuronal cell damage via cellular prion protein.
    Park YG; Moon JH; Park SY
    Neuroscience; 2014 Aug; 274():187-97. PubMed ID: 24875174
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Analysis of HIF-1a and its regulator, PHD2, in retroperitoneal sarcomas: clinico-pathologic implications.
    Huang JH; Lee FS; Pasha TL; Sammel MD; Karakousis G; Xu G; Fraker D; Zhang PJ
    Cancer Biol Ther; 2010 Feb; 9(4):303-11. PubMed ID: 20026900
    [TBL] [Abstract][Full Text] [Related]  

  • 109. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.
    Berra E; Benizri E; Ginouvès A; Volmat V; Roux D; Pouysségur J
    EMBO J; 2003 Aug; 22(16):4082-90. PubMed ID: 12912907
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
    Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
    Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Hypoxia-Inducible Factor Stabilization as an Emerging Therapy for CKD-Related Anemia: Report From a Scientific Workshop Sponsored by the National Kidney Foundation.
    Wish JB; Eckardt KU; Kovesdy CP; Fishbane S; Spinowitz BS; Berns JS
    Am J Kidney Dis; 2021 Nov; 78(5):709-718. PubMed ID: 34332007
    [TBL] [Abstract][Full Text] [Related]  

  • 112. "Branched Tail" Oxyquinoline Inhibitors of HIF Prolyl Hydroxylase: Early Evaluation of Toxicity and Metabolism Using Liver-on-a-chip.
    Poloznikov AA; Nikulin SV; Zakhariants AA; Khristichenko AY; Hushpulian DM; Gazizov IN; Tishkov VI; Gazaryan IG
    Drug Metab Lett; 2019; 13(1):45-52. PubMed ID: 30488807
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Prolyl-4-hydroxylase 2 and 3 coregulate murine erythropoietin in brain pericytes.
    Urrutia AA; Afzal A; Nelson J; Davidoff O; Gross KW; Haase VH
    Blood; 2016 Nov; 128(21):2550-2560. PubMed ID: 27683416
    [TBL] [Abstract][Full Text] [Related]  

  • 114. [Hypoxia-responsive factor PHD2 and angiogenic diseases].
    Jia HZ; Kasim V; Xu ZL; Yang L; Wu SR
    Yao Xue Xue Bao; 2014 Feb; 49(2):151-7. PubMed ID: 24761603
    [TBL] [Abstract][Full Text] [Related]  

  • 115. [Future perspectives of treatment for anemia in chronic kidney disease (CKD) using hypoxia-inducible factor prolyl hydroxylase inhibitors].
    Nangaku M
    Rinsho Ketsueki; 2021; 62(8):938-943. PubMed ID: 34497234
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Prolyl hydroxylase 2: a promising target to inhibit hypoxia-induced cellular metabolism in cancer cells.
    Singh L; Aldosary S; Saeedan AS; Ansari MN; Kaithwas G
    Drug Discov Today; 2018 Nov; 23(11):1873-1882. PubMed ID: 29772209
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Screening prolyl hydroxylase domain 2 inhibitory activity of traditional Chinese medicine by CZE-UV.
    Zhang Y; Zhao M; Wang CB; Wang Y; Nsanzamahoro S; Zhu LL; Wang WF; Yang JL
    Electrophoresis; 2022 Aug; 43(15):1601-1610. PubMed ID: 35405037
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Discovery of Novel and Potent Prolyl Hydroxylase Domain-Containing Protein (PHD) Inhibitors for The Treatment of Anemia.
    Xu J; Ding X; Fu Y; Meng Q; Wang L; Zhang M; Xu C; Chen S; Aliper A; Ren F; Zhavoronkov A; Ding X
    J Med Chem; 2024 Jan; 67(2):1393-1405. PubMed ID: 38189253
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology.
    Dao JH; Kurzeja RJ; Morachis JM; Veith H; Lewis J; Yu V; Tegley CM; Tagari P
    Anal Biochem; 2009 Jan; 384(2):213-23. PubMed ID: 18952043
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2.
    Richardson NL; O'Malley LJ; Weissberger D; Tumber A; Schofield CJ; Griffith R; Jones NM; Hunter L
    Bioorg Med Chem; 2021 May; 38():116115. PubMed ID: 33862469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.